AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 11/30/19

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . The Santa rally appears to be coming early this year as traders look set to push Wall Street further into record high territory t...

Federal prosecutors open a criminal investigation into whether opioid companies violated the federal Controlled Substances Act, according to WSJ sources . More news on: Teva Pharmaceutical Industries Limited, Mallinckrodt plc, Johnson & Johnson, Stocks on the move, Healthcare sto...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that management will participate in a fireside chat at the Piper Jaffray 31st Annual Healthcare Conference in New York on Tuesday, December 3, 2019 at 10:00 a.m. Eastern Time. To access a live webcast of the presentation, visit Amn...

In July, I wrote an article on Amneal Pharmaceuticals, Inc. ( AMRX ) relating to the strong insider buying and how that could be seen as a positive catalyst. While insider buying is generally a good sign, there is no foolproof way to making money on the market. AMRX is a great example of thi...

The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with their 2019 Q3 earnings Read more ...

Alexion Pharmaceuticals (NASDAQ: ALXN ) initiated with Buy rating and $125 (15% upside) price target at SunTrust. More news on: Alexion Pharmaceuticals, Inc., Amgen Inc., Arcus Biosciences, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Image source: The Motley Fool. Amneal Pharmaceuticals, Inc.   (NYSE: AMRX) Q3 2019 Earnings Call Nov 6, 2019 , 8:30 a.m. ET Operator Continue reading

Amneal Pharmaceuticals Inc. (AMRX) Q3 2019 Results Conference Call November 06, 2019 08:30 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Chirag Patel - Co-Chief Executive Officer and President Chintu Patel - Co-Chief Executive Officer Todd Bra...

Amneal Pharmaceuticals ( AMRX -18.6% ) inks an agreement with privately held Kashiv BioSciences for exclusive U.S. rights to Phase 2-stage K127 (pyridostigmine) for the treatment of myasthenia gravis , a rare autoimmune disorder characterized by weakness in the skeletal muscles. More ...